See the factory by live video walkthrough
Book an on-site factory visit in GuangzhouProper labeling of eye care products for the US market is critical for compliance, consumer safety, and brand trust. Ingredient declaration accuracy, mandatory warnings, and awareness of common pitfalls can prevent costly recalls or…
Proper labeling of eye care products for the US market is critical for compliance, consumer safety, and brand trust. Ingredient declaration accuracy, mandatory warnings, and awareness of common pitfalls can prevent costly recalls or enforcement actions. This guide outlines key requirements and practical sourcing tips for buyers and brand owners in the eye care category.
| Label Element | Requirement | Common Failure |
|---|---|---|
| Ingredient List | Descending order of weight, INCI names | Use of trade names or missing trace ingredients |
| Warnings | Specific to product type (cosmetic vs. OTC) | Generic warnings lacking required FDA language |
| Claims | Aligned to category, substantiated | Therapeutic claim on cosmetic SKU |
| Font & Visibility | Legible, minimum font size standards | Oversized label art reducing text space |
No, Drug Facts panels are only required for OTC drug products. Cosmetic eye care items must still follow 21 CFR 701 regarding ingredient declaration.
No. Use the correct INCI name to meet regulatory standards and improve ingredient transparency.
They are mandatory for OTC drugs and strongly recommended for cosmetics that have any potential irritation risk.
Redness relief may be considered a drug claim in the US—consult with regulatory experts before finalizing the label.
Not exactly; cosmetics have different guidelines but should disclose known sensitizers to maintain consumer trust.